These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7274028)

  • 1. New drug evaluations amiloride (Midamor, Merck, Sharp and Dohme).
    Macfie HL; Colvin CL; Anderson PO
    Drug Intell Clin Pharm; 1981 Feb; 15(2):94-8. PubMed ID: 7274028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance of potassium balance during diuretic therapy.
    Kohvakka A; Eisalo A; Manninen V
    Acta Med Scand; 1979; 205(4):319-24. PubMed ID: 373393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Potassium-sparing diuretics (spironolactone, triamterene, amylorid)].
    Haris A; Radó J
    Orv Hetil; 1996 Sep; 137(35):1907-14. PubMed ID: 8927344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure lowering and potassium conservation by triamterene-hydrochlorothiazide and amiloride-hydrochlorothiazide in hypertension.
    Maxwell MH; Brachfeld J; Itskovitz H; Lunn JA; Moser M; Zawada ET
    Clin Pharmacol Ther; 1985 Jan; 37(1):61-5. PubMed ID: 3880686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term metabolic effects of spironolactone and thiazides combined with potassium-sparing agents for treatment of essential hypertension.
    Jeunemaitre X; Charru A; Chatellier G; Degoulet P; Julien J; Plouin PF; Corvol P; Ménard J
    Am J Cardiol; 1988 Nov; 62(16):1072-7. PubMed ID: 3189169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance of potassium balance during long-term diuretic therapy in chronic heart failure patients with thiazide-induced hypokalemia: comparison of potassium supplementation with potassium chloride and potassium-sparing agents, amiloride and triamterene.
    Kohvakka A
    Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):273-7. PubMed ID: 3045028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action, pharmacokinetics, adverse effects, and therapeutic uses of amiloride hydrochloride, a new potassium-sparing diuretic.
    Vidt DG
    Pharmacotherapy; 1981; 1(3):179-87. PubMed ID: 6927605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive therapy with triamterene-hydrochlorothiazide vs amiloride-hydrochlorothiazide. Comparison of effects on urinary prostaglandin E2 excretion.
    Zawada ET
    Arch Intern Med; 1986 Jul; 146(7):1312-4. PubMed ID: 3521523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacology of potassium-sparing diuretics: amiloride and triamterene].
    Rorive G; Bovy P
    Coeur Med Interne; 1978; 17(2):207-15. PubMed ID: 350481
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of thiazides and amiloride in treatment of moderate hypertension.
    Thomas JP; Thomson WH
    Br Med J (Clin Res Ed); 1983 Jun; 286(6383):2015-8. PubMed ID: 6409208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients.
    Ramsay LE; Hettiarachchi J; Fraser R; Morton JJ
    Clin Pharmacol Ther; 1980 Apr; 27(4):533-43. PubMed ID: 7357812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of diuretic-induced hypokalemia by amiloride, a potassium-sparing agent.
    Ram CV; Holland OB; Kaplan NM
    J Clin Pharmacol; 1981; 21(11):484-7. PubMed ID: 7334141
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the potassium- retaining effects of amiloride and spironolactone in hypertensive patients with thiazide-induced hypokalaemia.
    George CF; Breckenridge AM; Dollery CT
    Lancet; 1973 Dec; 2(7841):1288-91. PubMed ID: 4127641
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral potassium chloride and amiloride in hydrochlorothiazide-induced potassium loss.
    Maronde RF; Barr J; Vlachakis ND; Spencer CA; Chan L
    Clin Pharmacol Ther; 1984 Oct; 36(4):431-5. PubMed ID: 6478730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical use of the potassium-sparing diuretics.
    Krishna GG; Shulman MD; Narins RG
    Semin Nephrol; 1988 Dec; 8(4):354-64. PubMed ID: 3068756
    [No Abstract]   [Full Text] [Related]  

  • 16. Potassium conservation with amiloride/hydrochlorothiazide ("Moduret') in thiazide-induced hypokalaemia in hypertension.
    Fernandez PG; Sharma JN; Galway AB; Campbell N; Kim BK; Snedden W; Granter-Button S; MacDonald J; Gill V
    Curr Med Res Opin; 1982; 8(2):120-7. PubMed ID: 7049587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of the hypotensive action of monotherapy using hydrochlorothiazide and its combination with triamterene and amiloride and their effect on hemodynamics at rest and during exercise therapy].
    Glezer GA; Lipko DS; Levinzon AM
    Kardiologiia; 1990 Jul; 30(7):11-3. PubMed ID: 2232453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potassium-sparing diuretics: spironolactone v. triamterene and amiloride.
    Drug Ther Bull; 1972 Apr; 10(8):30-2. PubMed ID: 5038791
    [No Abstract]   [Full Text] [Related]  

  • 19. Paradoxical reversal of the suppressed potassium secretion during treatment with combinations of antikaluretic agents (spironolactone, canrenone, triamterene, amiloride); a possible site of action in Henle's loop.
    Radó JP; Sawinsky I; Juhos E
    Horm Metab Res; 1976 May; 8(3):250-1. PubMed ID: 939474
    [No Abstract]   [Full Text] [Related]  

  • 20. Treating essential hypertension. The first choice is usually a thiazide diuretic.
    Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.